MedTrace Logo

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee

NCT00955552 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-02-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the efficacy and safety of glucosamine and chondroitin sulfate association in the treatment of patients with osteoarthrosis of the knee.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

Glucosamine sulphate and chondroitin sulphate association

glucosamine sulphate 500 mg and chondroitin sulphate 400 mg association T.I.D. before each meal

DRUG

Cosamin DS® (Nutramax)

oral capsule of glucosamine hydrochloride 500 mg + chondroitin sulphate 400 mg thrice daily before meals. Period: 127 days

Sponsors & Collaborators

  • Eurofarma Laboratorios S.A.

    lead INDUSTRY

Principal Investigators

  • Gilberto Brandão, Phd/MD · Centro de Pesquisa Clínica Perdizes

  • Marise L. Castro, Phd/MD · Instituto de Medicina Avancada

  • Cristiano F. Zerbini, Phd/MD · Centro Paulista de Investigacoes Clínicas Ltda.

  • Jose A. Mendonça, Phd/MD · Instituo de Pesquisa Clínica e Assistencia Medica de Campinas

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-02-28
Completion
2011-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00955552 on ClinicalTrials.gov